Growth factor receptor tyrosine kinases.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Annual Review of Biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/ANNUREV.BI.57.070188.002303PMID 3052279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human proto‐oncogene c‐kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

  1987cited by this paper
• erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

  1987cited by this paper
• Acute insulin action requires insulin receptor kinase activity: introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulin.

  1987cited by this paper
• Involvement of common and cell type-specific pathways in c-fos gene control: stable induction of cAMP in macrophages.

  1987cited by this paper
• Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

  1987cited by this paper
• Transforming potential of the c-fms proto-oncogene (CSF-1 receptor)

  1987cited by this paper
• Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.

  1987cited by this paper
• Insulin-activated tyrosine phosphorylation of a 15-kilodalton protein in intact 3T3-L1 adipocytes.

  1987cited by this paper
• Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms.

  1987cited by this paper
• High-affinity interleukin 2 binding by an oncogenic hybrid interleukin 2-epidermal growth factor receptor molecule.

  1987cited by this paper
• Heterologous transmembrane signaling by a human insulin receptor-v-ros hybrid in Chinese hamster ovary cells.

  1987cited by this paper
• Stimulation of epidermal growth factor receptor threonine 654 phosphorylation by platelet-derived growth factor in protein kinase C-deficient human fibroblasts.

  1987cited by this paper
• Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation.

  1987cited by this paper
• Identification of insulin receptor tyrosine residues autophosphorylated in vitro.

  1987cited by this paper
• Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene

  1987cited by this paper
• Phosphorylation of Purified Insulin Receptor by cAMP Kinase

  1987cited by this paper
• Gene transfer and molecular cloning of the rat nerve growth factor receptor

  1987cited by this paper
• A chimeric, ligand-binding v-erbB/EGF receptor retains transforming potential.

  1987cited by this paper
• Insulin-like growth factor I rapidly stimulates tyrosine phosphorylation of a Mr 185,000 protein in intact cells.

  1987cited by this paper
• ret transforming gene encodes a fusion protein homologous to tyrosine kinases

  1987cited by this paper
• Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity.

  1987cited by this paper
• Tyrosine phosphorylation of common and specific sets of cellular proteins rapidly induced by insulin, insulin-like growth factor I, and epidermal growth factor in an intact cell.

  1987cited by this paper
• Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor.

  1987cited by this paper
• Processing of the platelet-derived growth factor receptor. Biosynthetic and degradation studies using anti-receptor antibodies.

  1987cited by this paper
• Antibody-induced down-regulation of a mutated insulin receptor lacking an intact cytoplasmic domain.

  1987cited by this paper
• After insulin binds.

  1987cited by this paper
• Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor.

  1987cited by this paper
• Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.

  1987cited by this paper
• Sevenless, a cell-specific homeotic gene of Drosophila, encodes a putative transmembrane receptor with a tyrosine kinase domain.

  1987cited by this paper
• The insulin receptor. Structural basis for high affinity ligand binding.

  1987cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• An insertional mutant of epidermal growth factor receptor allows dissection of diverse receptor functions.

  1987cited by this paper
• Primary structure and biochemical properties of an M2 muscarinic receptor.

  1987cited by this paper
• Receptors for epidermal growth factor and other polypeptide mitogens.

  1987cited by this paper
• Effect of cyclic AMP-dependent protein kinase on insulin receptor tyrosine kinase activity.

  1987cited by this paper
• The protein-tyrosine kinase activity of the insulin receptor is necessary for insulin-mediated receptor down-regulation.

  1987cited by this paper
• Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding

  1986cited by this paper
• A calcium-dependent 35-kilodalton substrate for epidermal growth factor receptor/kinase isolated from normal tissue.

  1986cited by this paper
• Tumor-promoting phorbol esters increase the Km of the ATP-binding site of the insulin receptor kinase from rat adipocytes.

  1986cited by this paper
• Phosphorylation of receptors for insulin and insulin-like growth factor I. Effects of hormones and phorbol esters.

  1986cited by this paper
• Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor

  1986cited by this paper
• Phosphorylation of synthetic insulin receptor peptides by the insulin receptor kinase and evidence that the preferred sequence containing Tyr-1150 is phosphorylated in vivo.

  1986cited by this paper
• Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase.

  1986cited by this paper
• Differences in sequences encoding the carboxyl-terminal domain of the epidermal growth factor receptor correlate with differences in the disease potential of viral erbB genes.

  1986cited by this paper
• The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity.

  1986cited by this paper
• Phospholipid-dependent Ca2+ binding by the 36-kDa tyrosine kinase substrate (calpactin) and its 33-kDa core.

  1986cited by this paper
• The avian beta-adrenergic receptor: primary structure and membrane topology.

  1986cited by this paper
• Effects of protein kinase C activation after epidermal growth factor binding on epidermal growth factor receptor phosphorylation.

  1986cited by this paper
• The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats.

  1986cited by this paper
• Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin.

  1986cited by this paper
• cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines

  1986cited by this paper
• Early signals in the mitogenic response.

  1986cited by this paper
• The biology of platelet-derived growth factor

  1986cited by this paper
• Specific cleavage of the fibroblast receptor for platelet-derived growth factor by an endogenous Ca2+-dependent thiol protease.

  1986cited by this paper
• The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line

  1986cited by this paper
• Insulin activation of insulin receptor tyrosine kinase in intact rat adipocytes. An in vitro system to measure histone kinase activity of insulin receptors activated in vivo.

  1986cited by this paper
• Autophosphorylation of the insulin receptor in vitro. Designation of phosphorylation sites and correlation with receptor kinase activation.

  1986cited by this paper
• Structural requirements for the transmembrane activation of the insulin receptor kinase.

  1986cited by this paper
• Epidermal growth factor (EGF) promotes phosphorylation at threonine-654 of the EGF receptor: possible role of protein kinase C in homologous regulation of the EGF receptor

  1986cited by this paper
• Increasing the cAMP content of IM-9 cells alters the phosphorylation state and protein kinase activity of the insulin receptor.

  1986cited by this paper
• Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.

  1986cited by this paper
• A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences

  1986cited by this paper
• Lack of association of epidermal growth factor-, insulin-, and serum-induced mitogenesis with stimulation of phosphoinositide degradation in BALB/c 3T3 fibroblasts.

  1986cited by this paper
• Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase.

  1986cited by this paper
• Microaggregation of hormone‐occupied epidermal growth factor receptors on plasma membrane preparations.

  1986cited by this paper
• The neu oncogene encodes an epidermal growth factor receptor-related protein

  1986cited by this paper
• Possible involvement of protein kinase C and calcium ion in growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts.

  1986cited by this paper
• A lysine in the ATP‐binding site of P130gag‐fps is essential for protein‐tyrosine kinase activity.

  1986cited by this paper
• Alternative 5' exons and tissue-specific expression of the Drosophila EGF receptor homolog transcripts.

  1986cited by this paper
• Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.

  1986cited by this paper
• Cross-linking of epidermal growth factor receptors in intact cells: detection of initial stages of receptor clustering and determination of molecular weight of high-affinity receptors.

  1986cited by this paper
• Induction of c-fos and c-myc mRNA by epidermal growth factor or calcium ionophore is cAMP dependent.

  1986cited by this paper
• Isolation of a Drosophila genomic sequence homologous to the kinase domain of the human insulin receptor and detection of the phosphorylated Drosophila receptor with an anti-peptide antibody.

  1986cited by this paper
• Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line

  1986cited by this paper
• Insulin and growth factor effects on c-fos expression in normal and protein kinase C-deficient 3T3-L1 fibroblasts and adipocytes.

  1986cited by this paper
• "Replacement" of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential.

  1986cited by this paper
• Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

  1986cited by this paper
• Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor

  1986cited by this paper
• The interaction of 125I-colony-stimulating factor-1 with bone marrow-derived macrophages.

  1986cited by this paper
• Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

  1986cited by this paper
• Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms.

  1986cited by this paper
• Linking functional domains of the human insulin receptor with the bacterial aspartate receptor.

  1986cited by this paper
• Suppression of protein tyrosine kinase activity of the epidermal growth factor receptor by epidermal growth factor.

  1986cited by this paper
• Receptor aggregation is necessary for activation of the soluble insulin receptor kinase.

  1986cited by this paper
• Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors

  1986cited by this paper
• Tyrosine phosphorylation of insulin receptor beta subunit activates the receptor tyrosine kinase in intact H-35 hepatoma cells.

  1986cited by this paper
• Proto-oncogene c-ros codes for a molecule with structural features common to those of growth factor receptors and displays tissue specific and developmentally regulated expression

  1986cited by this paper
• Early phosphorylation events following the treatment of Swiss 3T3 cells with bombesin and the mammalian bombesin‐related peptide, gastrin‐releasing peptide.

  1986cited by this paper
• Expression of the c-myb proto-oncogene during cellular proliferation

  1986cited by this paper
• Rous-associated virus 1-induced erythroleukemic cells exhibit a weakly transformed phenotype in vitro and release c-erbB-containing retroviruses unable to transform fibroblasts

  1986cited by this paper
• A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor

  1986cited by this paper
• Expression and structure of the human NGF receptor.

  1986cited by this paper
• Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization.

  1986cited by this paper
• The protein-tyrosine kinase substrate, p81, is homologous to a chicken microvillar core protein

  1986cited by this paper
• Large deletions in the cytoplasmic kinase domain of the epidermal growth factor receptor do not affect its laternal mobility

  1986cited by this paper
• A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family

  1986cited by this paper
• Evolutionary conserved close linkage of the c‐fes/fps proto‐oncogene and genetic sequences encoding a receptor‐like protein.

  1986cited by this paper
• Norepinephrine decreases EGF binding in primary rat hepatocyte cultures

  1986cited by this paper
• Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus

  1986cited by this paper
• High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines.

  1986cited by this paper

• Vascular Endothelial Growth Factor Receptors in the Vascularization of Pancreatic Tumors: Implications for Prognosis and Therapy

  2025influential citation
• Macrocyclic peptides targeting human CD44 inhibit cell adhesion.

  2025cites this paper
• Structural analysis of HER2-trastuzumab complex reveals receptor conformational adaptation

  2025cites this paper
• A Canine c-kit Novel Mutation Isolated from a Gastrointestinal Stromal Tumor (GIST) Retains the Ability to Form Dimers but Lacks Autophosphorylation

  2025cites this paper
• Binding affinity and structural dynamics of amygdalin-HER2 interactions: An investigation for breast cancer therapy

  2025cites this paper
• Agonist Discovery for Membrane Proteins on Live Cells by Using DNA-encoded Libraries.

  2024cites this paper
• MicroRNA-34 and gastrointestinal cancers: a player with big functions

  2024cites this paper
• Targeting Cancer Hallmarks Using Selected Food Bioactive Compounds: Potentials for Preventive and Therapeutic Strategies

  2024cites this paper
• 2-Isopropyl-4-methoxy-5-methylphenol-Hydrazone Derivatives: Synthesis, Characterization, and In-Silico Assessment of EGFR and Bcl2 Inhibitory Activity

  2024cites this paper
• Regulation of cell proliferation and tumor suppressor roles of microRNA 329-3p of the MAP kinase pathway in cervical squamous carcinoma

  2024cites this paper
• OptoREACT: Optogenetic Receptor Activation on Nonengineered Human T Cells.

  2024cites this paper
• Synthesis, Spectroscopic Analysis, Molecular Docking and DFT Study of Novel 1,2,3-Triazole Derivatives Incorporating paramethoxythymol and Salicylaldehyde Moieties

  2024cites this paper
• Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship.

  2023cites this paper
• Molecular dynamics simulations reveal phosphorylation-induced conformational dynamics of the fibroblast growth factor receptor 1 kinase

  2023cites this paper
• Potential role of Marine Bioactive Compounds targeting signaling pathways in cancer: A review.

  2022cites this paper
• Recent progress in the manipulation of biochemical and biophysical cues for engineering functional tissues

  2022cites this paper
• Role and significance of c-KIT receptor tyrosine kinase in cancer: A review

  2022cites this paper
• Phase separation ability and phosphatase activity of the SHP1-R360E mutant.

  2022cites this paper
• Insulin-like Peptide Receptor (ILPR) in the Cuttlefish Sepiella japonica: Characterization, Expression, and Regulation of Reproduction

  2022cites this paper
• Effects of EGFR inhibitor AG 1478 on MDA-MB-231 and MCF-7 breast cancer cells

  2021cites this paper
• Novel Benzothiazole Hybrids Targeting EGFR: Design, Synthesis, Biological Evaluation and Molecular Docking Studies

  2021cites this paper
• Growth Factors

  2021cites this paper
• Stem cell culture media enriched with plant‐derived compounds: Cell proliferation enhancement

  2021cites this paper
• Curcumin encapsulation in functional PLGA nanoparticles: A promising strategy for cancer therapies.

  2021cites this paper
• Activation Of Insulin Receptor Signaling Pathway Using Ligand Microbeads In Mammalian Cells And Isolation Of Receptor-Bead Complex

  2021cites this paper
• Leucine-rich repeat receptor-like protein kinase AtORPK1 promotes oxidative stress resistance in an AtORPK1-AtKAPP mediated module in Arabidopsis.

  2021cites this paper
• Stem cell culture media enriched with plant‐derived compounds: Cell differentiation enhancement

  2021cites this paper
• A DNA Aptamer That Inhibits the Aberrant Signaling of Fibroblast Growth Factor Receptor in Cancer Cells

  2021cites this paper
• Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment.

  2020cites this paper
• HER family in cancer progression: From discovery to 2020 and beyond.

  2020cites this paper
• Growth Factor Receptor

  2020cites this paper
• Cancer of the Esophagus

  2020cites this paper
• Prognostic Implications of EGFR, p53, p16, Cyclin D1, and Bcl‐2 in Head and Neck Squamous Cell Carcinoma (HNSCC)

  2020cites this paper
• Clinical Study Protocol

  2020cites this paper
• HER2/neu Oncogene and Sensitivity to the DNA-Interactive Drug Doxorubicin

  2020cites this paper
• Cancer biology and other disorders: beneficial role of camptothecin and novel derivatives

  2020cites this paper
• Combinatorial drug therapy in cancer - New insights.

  2020cites this paper
• Identification of novel point mutations in c-kit gene from Leukemia cases: a study from Lucknow, Uttar Pradesh, India

  2020cites this paper
• Genome-Wide Characterization, Evolution, and Expression Analysis of the Leucine-Rich Repeat Receptor-Like Protein Kinase (LRR-RLK) Gene Family in Medicago truncatula

  2020cites this paper
• Signals for Nuclear Localization in Pdgf-Related Proteins

  2020cites this paper
• Quantifying the strength of heterointeractions among receptor tyrosine kinases from different subfamilies: Implications for cell signaling

  2020cites this paper
• The equine mononuclear phagocyte system: the relevance of the horse as a model for understanding human innate immunity.

  2020cites this paper
• Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer

  2020cites this paper
• Generation and Modeling of Radiation for Clinical and Research Applications

  2019cites this paper
• Embryonic Stem Cell-Derived Exosomes Increase the Antiproliferative Activity of Doxorubicin in Breast Cancer

  2019cites this paper
• Profiling the phosphotyrosine interactome of receptor tyrosine kinases by affinity enrichment-mass spectrometry

  2019influential citation
• The use of proteomic technologies to study molecular mechanisms of multidrug resistance in cancer.

  2019cites this paper
• A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy.

  2019cites this paper
• The promising role of monoclonal antibodies for gastric cancer treatment.

  2019cites this paper
• Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities

  2019cites this paper
• Hydroxyapatite-based materials for smart antitumor drug delivery systems, endocytic pathways and endosomal trafficking : polymers and biopolymers

  2019cites this paper
• Can resveratrol attenuate testicular damage in neonatal and adult rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin during gestation?

  2018cites this paper
• Regulation of microRNA Expression by Growth Factors in Tumor Development and Progression

  2018cites this paper
• MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma

  2018cites this paper
• Activated receptor tyrosine kinases in granulosa cells of ovulating follicles in mice

  2018cites this paper
• Investigations of Leucine-rich repeats and immunoglobulin-like domain-proteins 1 and 2 (LRIG1 and LRIG2) and their genes in cancer

  2018cites this paper
• The RTK Interactome: Overview and Perspective on RTK Heterointeractions.

  2018cites this paper
• RON Receptor Tyrosine Kinase in Pancreatic Cancer Progression

  2018cites this paper
• Protein tyrosine kinase inhibitors

  2018cites this paper
• Identification of markers for human endometrial carcinoma stem cells

  2017cites this paper
• Rôle de la GTPase ARF1 dans la migration et l’invasion des cellules du cancer du sein

  2017cites this paper
• Rôle de TLR7 dans la progression tumorale dans le cancer du poumon

  2017cites this paper
• The tyrosine phosphatase SHP-1 promotes T cell adhesion by activating the adaptor protein CrkII in the immunological synapse

  2017cites this paper
• Monitoring Cancer Response to Treatment with Hyperpolarized 13 C MRS

  2017cites this paper
• Non-melanoma skin cancer: new and future synthetic drug treatments

  2017cites this paper
• Stratified medicine: methods for evaluation of predictive biomarkers

  2017cites this paper
• Positive Mediators of Cell Proliferation in Neoplasia: Growth Factors and Receptors

  2017cites this paper
• Epidemiological and immunological study for intractable infectious diseases in livestock

  2017cites this paper
• Beta-arrestins in cancer : linking pro-tumorigenic extracellular activated signaling with the tumor suppressor p53 pathway

  2017cites this paper
• Effects of FGFR2 kinase activation loop dynamics on catalytic activity

  2017cites this paper
• Resistance to Tyrosine Kinase Inhibitors in Different Types of Solid Cancer

  2016cites this paper
• EGFR Over-expression in Head and Neck Squamous Carcinoma & It's Correlation with Etiological Factors like Alcohol and Tobacco

  2016cites this paper
• Preparation and In Vitro Evaluation of Antitumor Activity of TGFαL3-SEB as a Ligand-Targeted Superantigen

  2016cites this paper
• Clinical Evaluation of Insulin like Growth Factor-I and Vascular Endothelial Growth Factor with Alloplastic Bone Graft Material in the Management of Human Two Wall Intra-Osseous Defects.

  2016cites this paper
• The role of Src family kinases in macrophage motility and invasive capacity

  2016cites this paper
• Drosophila Protein Kinase CK2: Genetics, Regulatory Complexity and Emerging Roles during Development

  2016cites this paper
• Regulation of Growth Factor Receptors by Glycosphingolipids

  2016cites this paper
• Exploration of Anticancer Potential of Spiropyranopyrazole Derivatives as CDK7 Inhibitors

  2016cites this paper
• Expression and function of APELA : a potential regulator of cell growth in human cancers

  2016cites this paper
• FLT3 Gene Mutation Profile and Prognosis in Adult Acute Myeloid Leukemia.

  2016cites this paper
• Targeting Myc-driven tumours - BETing on ATR

  2016cites this paper
• Ligand-dependent responses of the silkworm prothoracicotropic hormone receptor, Torso, are maintained by unusual intermolecular disulfide bridges in the transmembrane region

  2016cites this paper
• Genetic Mutations in Acute Myeloid Leukemia

  2016cites this paper
• In vitro and in vivo models to assess the mechanism of lapatinib-induced diarrhoea

  2016cites this paper
• Intestinal Tumorigenesis

  2015cites this paper
• intercross of Brown Norway and Dahl S rats Genetically defined risk of salt sensitivity in an

  2015cites this paper
• Receptor Tyrosine Kinase Signal Transduction and the Molecular Basis of Signalling Specificity

  2015cites this paper
• Highly expressed EGFR in pearl sac may facilitate the pearl formation in the pearl oyster, Pinctada fucata.

  2015cites this paper
• Nonirradiated NOD,B6.SCID Il2rγ−/−KitW41/W41 (NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic Cells

  2015influential citation
• Receptor Tyrosine Kinases: Structure, Functions and Role in Human Disease

  2015cites this paper
• The Effect of Freud-1/CC2D1A Knockout on EGF Receptor Activation

  2015cites this paper
• Gastric cancer and the epoch of immunotherapy approaches.

  2015cites this paper
• Mutation-introduced dimerization of receptor tyrosine kinases: from protein structure aberrations to carcinogenesis

  2015cites this paper
• Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents.

  2015cites this paper
• Growth and Neurotrophic Factor Receptors in Neural Differentiation and Phenotype Specification

  2015cites this paper
• In silico and in vitro studies of novel 7-azaindole and 7-azaisatin derivatives as potent anticancer agents

  2015cites this paper
• Molecular characterization of T‐cell immunoglobulin mucin domain‐3 and Galectin‐9 genes of swamp‐ and riverine‐type water buffaloes

  2015cites this paper
• Gene Mutations in Acute Myeloid Leukemia — Incidence, Prognostic Influence, and Association with Other Molecular Markers

  2015cites this paper
• Mechanistic Implications and Characterization of Anaplastic Lymphoma Kinase (ALK) mutations in Neuroblastoma

  2015cites this paper
• Patologi Targeting chronic lymphocytic leukemia cells using anti-ROR 1 monoclonal antibodies and small molecule inhibitors

  2015cites this paper